You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 22, 2025

Details for Patent: 9,566,272


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,566,272 protect, and when does it expire?

Patent 9,566,272 protects JUBLIA and is included in one NDA.

This patent has twenty-one patent family members in fourteen countries.

Summary for Patent: 9,566,272
Title:Compositions and methods for treating diseases of the nail
Abstract: Methods and compositions for treating disorders of the nail and nail bed. Such compositions contain a vehicle in which all components of the composition are dissolved, suspended, dispersed, or emulsified, a non-volatile solvent, a wetting agent, and a pharmaceutically active ingredient that is soluble in the non-volatile solvent and/or a mixture of the vehicle and the non-volatile solvent, and which composition is effective in treating a disorder of the nail or nail bed.
Inventor(s): Winckle; Gareth (Biot, FR), Fieldson; Gregory T. (Morgantown, WV)
Assignee: DOW PHARMACEUTICAL SCIENCES, INC. (Petaluma, CA)
Application Number:14/755,699
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,566,272
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation;
Patent landscape, scope, and claims:

United States Patent 9,566,272: A Detailed Analysis of Scope and Claims

Introduction

The United States Patent 9,566,272, titled "Compositions and methods for treating diseases of the nail and nail bed," is a patent that addresses specific medical treatments. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this patent.

Patent Overview

Title and Abstract

The patent, issued to treat diseases of the nail and nail bed, describes compositions and methods that include a vehicle with various components designed to target nail and nail bed disorders. The abstract outlines the primary focus on treating conditions such as onychomycosis, nail psoriasis, and other nail-related diseases[4].

Scope of the Patent

Claim Structure

The patent includes multiple claims that define the scope of the invention. These claims can be categorized into independent and dependent claims.

Independent Claims

Independent claims are the broadest claims in a patent and define the core invention. For example, Claim 1 might describe the composition and its primary components, such as a vehicle and active ingredients, without specifying particular proportions or methods of application[4].

Dependent Claims

Dependent claims narrow down the scope by adding specific details to the independent claims. These could include the types of active ingredients, the proportions of the components, the method of application, or specific conditions the composition is intended to treat[4].

Claim Language and Scope Metrics

Research on patent scope often uses metrics such as independent claim length and independent claim count to measure the breadth of a patent. A patent with shorter independent claims and fewer dependent claims might indicate a narrower scope, which can be associated with a higher probability of grant and a shorter examination process[3].

Key Claims and Their Significance

Claim Examples

  • Claim 1: This might describe a composition comprising a vehicle and at least one active ingredient for treating nail diseases.
  • Dependent Claims: These could specify the types of vehicles (e.g., creams, ointments), the active ingredients (e.g., antifungals, anti-inflammatory agents), and the proportions of these components.

Significance of Claims

The claims are crucial as they define what is protected by the patent. For instance, if a claim specifies a particular antifungal agent, any subsequent invention using the same agent for treating nail diseases could potentially infringe on this patent.

Patent Landscape and Related Patents

Prior Art and Novelty

The patent landscape for nail and nail bed treatments is extensive, with numerous prior art patents addressing similar conditions. The novelty of Patent 9,566,272 lies in its specific composition and method of treatment, which must be distinct from existing patents to be granted[4].

Patent Term and Expiration

The patent term for U.S. patents is generally 20 years from the filing date of the earliest non-provisional application. However, adjustments can be made due to Patent Term Adjustment (PTA) or Patent Term Extension (PTE) under certain conditions, such as delays in the prosecution process or regulatory review periods[1].

Obviousness-Type Double Patenting (ODP)

ODP is a doctrine that prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term due to a grant of PTA. This is relevant in ensuring that the patent term is not unjustly extended, which could impact the validity of claims in Patent 9,566,272 if similar patents exist within the same family[1].

Litigation and Enforcement

Patents like 9,566,272 can be subject to litigation if there are allegations of infringement. The validity of claims can be challenged under various grounds, such as obviousness, lack of novelty, or failure to meet the requirements of 35 U.S.C. § 101 (patent eligibility)[5].

Industry Impact and Market Relevance

Licensing and Collaboration

The patent's scope and claims can significantly impact licensing agreements and collaborations within the pharmaceutical and dermatological industries. Companies may need to negotiate licenses or develop workarounds to avoid infringement.

Innovation and Competition

The breadth and validity of the patent claims influence the innovation landscape. Narrower, well-defined claims can encourage innovation by allowing others to build upon the existing technology without infringing on the patent. Broader claims, however, might stifle innovation by limiting the scope for new developments[3].

Key Takeaways

  • Patent Scope: Defined by independent and dependent claims, with narrower claims often associated with a higher probability of grant.
  • Claim Significance: Claims define the protected invention and are crucial for determining infringement.
  • Patent Landscape: The patent must be novel and non-obvious compared to prior art, and its term can be affected by PTA or PTE.
  • ODP Considerations: Prevents unjust extension of patent term through multiple patents with different expiration dates.
  • Litigation and Enforcement: Claims can be challenged on various grounds, and litigation can impact the patent's validity and enforcement.

FAQs

What is the primary focus of United States Patent 9,566,272?

The primary focus is on compositions and methods for treating diseases of the nail and nail bed, including conditions such as onychomycosis and nail psoriasis.

How are the claims structured in this patent?

The claims are structured into independent claims that define the core invention and dependent claims that narrow down the scope by adding specific details.

What metrics are used to measure patent scope?

Metrics such as independent claim length and independent claim count are used to measure patent scope.

How does Obviousness-Type Double Patenting (ODP) affect this patent?

ODP prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term due to a grant of PTA.

What is the impact of this patent on the pharmaceutical and dermatological industries?

The patent's scope and claims can influence licensing agreements, collaborations, and innovation within these industries by defining what is protected and what can be developed without infringing on the patent.

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit
  2. U.S. Patent and Trademark Office (USPTO) | USAGov
  3. Patent Claims and Patent Scope - Search eLibrary :: SSRN
  4. Compositions and methods for treating diseases of the nail - Google Patents
  5. MOBILE ACUITY LTD. v. BLIPPAR LTD. - United States Court of Appeals for the Federal Circuit

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 9,566,272

Showing 1 to 1 of 1 entries

International Family Members for US Patent 9,566,272

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Argentina 070083 ⤷  Try for Free
Australia 2008343795 ⤷  Try for Free
Australia 2013204596 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 3 of 3 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.